Chemed Shareholders Seeking to Recover Losses through Investor Lawsuit
Encouraged to Contact Securities Lawyers at Deans & Lyons LLP
DALLAS, May 30, 2013
DALLAS, May 30, 2013 /PRNewswire/ -- Securities lawyers are investigating
Chemed (NYSE: CHE) due to potential violations of shareholder protection laws.
Concerned CHE stockholders who seek to recover value for their shares should
contact securities lawyer Hamilton Lindley at 877-819-8033 or
firstname.lastname@example.org about potential investor claims.
Securities lawyers are investigating the company due to a False Claims Act
complaint filed by the U.S. Government. The allegations in that lawsuit
involve billing Medicare for unnecessary crisis care services and admitting
patients who were not eligible for the Medicare hospice benefit. On news of
this lawsuit, Chemed stock price dropped precipitously.
Deans & Lyons LLP has significant experience representing investors in
securities class action and derivative lawsuits nationwide. Stockholders with
concerns about their CHE stock or anyone with information about this situation
should contact Hamilton Lindley at email@example.com or 877-819-8033.
Deans & Lyons LLP
325 N. Saint Paul Street, Suite 1500
Dallas, TX 75201
(877) 819-8033 Toll Free
(214) 965-8500 Telephone
(214) 965-8505 Facsimile
SOURCE Deans & Lyons LLP
Press spacebar to pause and continue. Press esc to stop.